# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-069203
Filing Date
2025-05-12
Accepted
2025-05-12 16:10:30
Documents
75
Period of Report
2025-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | fgen-20250331.htm iXBRL | 10-Q | 2551208
2 | EX-10.1 | fgen-ex10_1.htm | EX-10.1 | 1215800
3 | EX-10.2 | fgen-ex10_2.htm | EX-10.2 | 30683
4 | EX-10.3 | fgen-ex10_3.htm | EX-10.3 | 30426
5 | EX-10.4 | fgen-ex10_4.htm | EX-10.4 | 56180
6 | EX-31.1 | fgen-ex31_1.htm | EX-31.1 | 10188
7 | EX-31.2 | fgen-ex31_2.htm | EX-31.2 | 10182
8 | EX-32.1 | fgen-ex32_1.htm | EX-32.1 | 10189
| Complete submission text file | 0000950170-25-069203.txt |  | 11757530

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | fgen-20250331.xsd | EX-101.SCH | 1817786
77 | EXTRACTED XBRL INSTANCE DOCUMENT | fgen-20250331_htm.xml | XML | 1518910

Mailing Address 350 BAY STREET SUITE 100 #6009 SAN FRANCISCO CA 94133
Business Address 350 BAY STREET SUITE 100 #6009 SAN FRANCISCO CA 94133 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36740 | Film No.: 25934899
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)